Common Contracts
2 similar Warrant Exchange Agreement contracts by Oxygen Biotherapeutics, Inc.
ContractWarrant Exchange Agreement • May 5th, 2020 • New York
EX-10.4 8 oxbt_ex104.htm WARRANT EXCHANGE AGREEMENT EXHIBIT 10.4 WARRANT EXCHANGE AGREEMENT This WARRANT EXCHANGE AGREEMENT (this “Agreement”), is dated as of February 21, 2013, by and between Oxygen Biotherapeutics, Inc., a Delaware corporation (the “Company”), and [____________] (the “Holder”). WHEREAS, the Company issued those certain Warrants to Purchase Common Stock (the “Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), issued by the Company on December 9, 2011 and June 15, 2012; WHEREAS, as of the date hereof, the Holder owns Warrants to purchase an aggregate of 675,677 shares of Common Stock (the “Warrant Shares”); WHEREAS, in order to improve the capital structure of the Company, the Company and the Holder desire to enter into this Agreement, pursuant to which, among other things, the Company and the Holder shall exchange the Warrants for an aggregate of 200,000 shares of Common Stock (the “Exchange Shares”) and $190
WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • February 25th, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • New York
This WARRANT EXCHANGE AGREEMENT (this “Agreement”), is dated as of February 21, 2013, by and between Oxygen Biotherapeutics, Inc., a Delaware corporation (the “Company”), and [____________] (the “Holder”).
